Renergen Locks In Another Take-or-Pay LNG Deal, Reaching 75% of Phase 1 Volumes
ASPI sits 17% above its 52-week low of $3.51.
Summary
A new five-year take-or-pay LNG contract lifts Phase 1 contracted volumes to ~75%, reinforcing the Virginia Gas Project's commercial viability ahead of its Q3 2026 startup.
Key Events · M&A and Partnerships · ASPI
-
New Take-or-Pay LNG Contract Signed
Tetra4, Renergen's subsidiary, entered a five-year take-or-pay LNG contract with a South African food processor at >$16/GJ, covering ~10% of Phase 1 nameplate capacity.
-
Phase 1 LNG Contracting Reaches ~75%
With this contract, Renergen has now secured take-or-pay agreements for approximately 75% of Phase 1 LNG volumes, significantly de-risking projected cash flows.
-
Revenue Visibility Strengthens
Assuming $15–18/GJ LNG and $600/Mcf helium, Phase 1 is expected to generate >$27M in annualized revenue, with commercial production targeted for Q3 2026.
-
Merger Context
The contract adds commercial momentum to the pending Noble Africa reverse merger with ENDRA Life Sciences, which will house these assets as a Nasdaq-listed entity.
Analysis · ASPI · Industrial Applications And Services
Renergen—the helium and LNG subsidiary slated to merge into ENDRA Life Sciences—has secured a five-year take-or-pay LNG contract with a domestic food processor at over $16/GJ. With this deal, contracted Phase 1 LNG volumes now stand at roughly 75%, materially de-risking the project's cash flows just as commercial production is set to commence in Q3 2026. The agreement adds visibility to the >$27M annualized revenue target and bolsters the investment case for the pending Noble Africa reverse merger.
At the time of this filing, ASPI was trading at $4.10 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $509.9M. The 52-week trading range was $3.51 to $14.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.